Search results for: 'disease border'

According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as ...

10 Feb 2022  |  North America  |  Market Research

Global Digital Smart Borders Growth Opportunities

Defining Future Growth Strategies for Different Ports of Entry

Infographics

×

Key Issues Addressed

The COVID-19 pandemic has hit the travel industry hard, with a total collapse of international travel. In 2020 and 2021, airline passenger numbers decreased by 60%, causing massive job and cumulative revenue losses of about $498 billion. The last 2 years have demonstrated that the world will likely continue to grapple with some form of the COVID-19...

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

Due to the gradual lifting of global COVID lockdowns and protocols, global travel and trade flows have resumed to near pre-pandemic levels. Economic and political crises worldwide, especially in Central America, have also caused a spike in immigration to the United States. These situations present challenges to border security authorities. In th...

The explosive growth of cross-border eCommerce is supported by the increasingly young and urban population with easy access to technology such as mobile phones and tablets. Cross-border eCommerce trade between Europe and Asia is significant, with China being the most popular country for online shoppers in the West, driven by low prices and a wide v...

06 Oct 2021  |  North America  |  Market Research

US Chronic Disease Management Growth Opportunities

Future Growth Potential Enhanced by the Pandemic and Growth Opportunities in Chronic Disease Management

Infographics

×

Key Issues Addressed

The prevalence of chronic diseases has continued to rise, and the expenses of managing them or treating the complications arising from poor management cost the US healthcare system hundreds of billions of dollars each year. Clearly, physicians alone cannot control this rising challenge, and to ensure behavioral change, several tools and approaches ...

Management of infectious diseases remains a critical challenge for public health professionals who face increasing demand to control the spread of existing and novel diseases. To provide appropriate healthcare assistance, it is imperative to diagnose the exact form of infection from an array of complicated symptoms expressed by the host. As the out...

The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...

This research service evaluates the global autoimmune disease diagnostics markets from 2009 to 2018. The market includes two segments, which include analysis for the markets for localized autoimmune disease diagnostic tests and for the systemic autoimmune disease diagnostic tests. This research service offers a discussion of the key market drivers ...